July 14th, 2011 by GarySchwitzer in Opinion
No Comments »
This is not a lesson about the limitations of 140-character messages on Twitter.
Rather, it is a warning about careless Tweets that mischaracterize the real meat of the message in longer stories linked to in the Twitter message. As I wrote on Twitter in response to these two episodes, “Better not to Tweet on complex health care topics than to mischaracterize your own story with a misleading 140 characters.”
First, my friend Andrew Holtz caught the fact earlier this week that Men’s Health Magazine tweeted:
If you’re a smoker, you NEED to get a CT scan. Here’s why: http://ow.ly/5x34y
That “here’s why” link took you to a Men’s Health Magazine story, that despite being headlined “The Medical Test Every Smoker Needs,” went on to explain:
Don’t run out and ask for a CT scan, though. More than 96 percent of the positive screens in the study were false positives, which could subject you to unnecessary surgery, cancer treatments, and the complications that come with them. They’re also expensive: A chest CT scan can cost up to several thousands of dollars.
So look at how silly Men’s Health looked on this confusing back-and-forth message:
1. You NEED to get a CT scan.
2. It’s a test “every smoker needs”
3. But don’t run out and ask for one.
Then this morning I caught AARP doing the same thing. They tweeted:
Are you a smoker? CT scan those lungs – they’re proven to cut risk of lung cancer death for 55-plus: http://aarp.us/rdleHu
That links takes you to a story that includes caveats such as the following: Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
July 9th, 2011 by GarySchwitzer in True Stories
3 Comments »
Marilyn Mann is a very smart woman. She’s a securities lawyer. But she’s also educated herself about health care out of necessity. She’s a breast cancer survivor and she has a daughter with heterozygous familial hypercholesterolemia, a genetic disease causing very high LDL-cholesterol. She is one of the administrators of a Facebook group called Familial Hypercholesterolemia (FH) Discussion Group – intended primarily for people with FH or their family members.
Recently, Mann got a message from a PR woman who had joined the Facebook page.
“Hi Marilyn,
A few months ago, I had emailed you about some research I was doing about a new treatment for FH. I am now working with a pharmaceutical company, and the company currently has a drug in development to help treat people with severe FH that may not be responding to current therapies. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
July 5th, 2011 by GarySchwitzer in News, Research
No Comments »
The Spine Journal has published a special June issue focusing on Medtronic’s INFUSE product, or rhBMP-2, a bone growth product commonly used in spine fusion surgeries. A journal news release states:
A critical review of 13 industry-sponsored studies on a spine surgery product found that the actual risk of adverse events was 10 to 50 times the estimates originally reported. The product in question is recombinant bone morphogenetic protein-2 (rhBMP-2), a controversial synthetic bone growth factor often used as a bone graft substitute in spine fusion surgeries. This eye-opening study, “A critical review of rhBMP-2 trials in spinal surgery: emerging safety concerns and lessons learned” is included in a special BMP-focused issue of The Spine Journal.
The comprehensive review found four main areas of concern among the 13 original industry-sponsored studies:
• Conflicts of interest were either not reported or were unclear in each study. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
June 19th, 2011 by GarySchwitzer in Opinion, Research
2 Comments »
This week has been proclaimed International Men’s Health Week – the week leading up to and including Father’s Day. And it’s part of what’s more broadly been proclaimed by some as Men’s Health Month.
The campaign offers a variety of men’s health “materials” – including the squeezy prostate stress ball pictured at left – if you’re into that kind of thing.
There are also brochures like the one below. The “Facts About Prostate Cancer” state that men at high risk should begin yearly screening at age 40 – all others at age 50. The “should begin (at 50)” recommendation crosses a line not supported by the US Preventive Services Task Force and the American Cancer Society, among other organizations.
The campaign also commits fear-mongering with these statistics: Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
June 12th, 2011 by GarySchwitzer in News
No Comments »
Those who market heart scan services should be more careful about what they promote and to whom.
When ProPublica’s Marshall Allen got a telemarketing offer for heart scans for him and his wife, he followed up with a story, “Body Imaging Business Pushes Scans Many Don’t Need – Including Me.”
Reminding Allen about the deaths of figure skater Sergei Grinkov, baseball player Darryl Kile, newsman Tim Russert and actor Patrick Swayze, the salesman said:
“You never know when it could happen. … Boom, you’re dead!” he exclaimed, slapping a desk for emphasis.
But Allen tells another story – of complaints by patients and regulators about the business. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
